Find a Clinical Trial

Filter

Showing 1 - 6 out of 6

HGB-210

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with the LentiGlobin BB305 Lentiviral Vector in Subjects with Sickle Cell Disease.

Sickle cell anemia

All genders

2-50

Recruiting now

Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center

Learn more

ANHL1931

ANHL1931: A Randomized Phase 3 trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

Lymphoma

All genders

Recruiting now

Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center

Learn more

ROACTIVE-HF II

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)

Heart failure

All genders

18+

Recruiting now

Division of Cardiology

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

Heart transplantation

All genders

18+

Recruiting now

CardioVascular Center

Learn more

ON-TRK

Prospective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

Solid tumors

All genders

No minimum age

Recruiting now

Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center

Learn more

Pulmonary vascular impedance in cardiogenic shock

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Heart failure, Shock

All genders

18+

Recruiting now

CardioVascular Center

Learn more

Filter

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo with the LentiGlobin BB305 Lentiviral Vector in Subjects with Sickle Cell Disease.

ANHL1931: A Randomized Phase 3 trial of Nivolumab in Combination with Chemo-immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-cell Lymphoma

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial)

OCS Heart Perfusion Post- Approval Registry

Prospective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib

Pulmonary vascular impedance as a novel tool to understand right ventricular afterload in cardiogenic shock

Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor
System in New York Heart Association (NYHA) Class II-III Heart Failure Patients
(PROACTIVE-HF-2 Trial)